Alexey V. Pshezhetsky , Ph.D.
    Alexey V. Pshezhetsky
    Research Axis
    Metabolic and Cardiovascular Health
    Research Theme
    Genetic and metabolic diseases in Quebec: diagnosis, mechanisms and interventions
    CHUSJ - Centre de Recherche

    514 345-4931 #2736

    514 345-4766


    • Professor, Department of Pediatrics, University of Montreal, 2006.
    • Adjunct Professor, Department of Anatomy and Cell Biology, McGill University, 2005.
    • Adjunct Professor, Department of Biochemistry, University of Montreal, 1998.


    • Postdoctorate in Medical Science, Academy of Medical Sciences, Moscow, Russia, 1990.
    • PhD in Biochemistry, Moscow State University, Russia, 1988.
    • Master's in Biochemistry, Moscow State University, Russia, 1985.

    Research Interests

    Lysosomal biology and lysosomal storage diseases

    Lysosomes are cytoplasmic organelles harbouring over 100 hydrolytic enzymes involved in the degradation of essentially all types of biological macromolecules. Any failure in the biogenesis, lysosomal targeting, supramolecular organization or function of one or more lysosomal enzymes can result in the progressive metabolic diseases known as lysosomal storage diseases because of the massive accumulation of the undegraded substrates of the deficient enzymes in the lysosomes of the affected tissues. Our research aims at discovering the genes mutated in lysosomal diseases, identifying the molecular and biochemical defects in patients and developing therapies with a special emphasis on diseases caused by deficiencies in lysosomal sialidases (sialidosis, galactosialidosis) and N-acetyltransferases (mucopolysaccharidosis IIIC).

    Sialic acids and sialidases in cell signalling

    Sialic acids are abundantly expressed on the cell surface and implicated in mediating recognition between the cells, between the cells and extracellular matrix as well as between the cells and a range of pathogenic viruses, bacteria and protozoa during the inflammatory and immune reactions. Much less is known about the role of sialidases (also called neuraminidases) and sialotransferases that can regulate cellular affinity by modifying the sialylation of cell surface molecules. Using the genetically targeted mouse models, we study the role of neuraminidase 1 (Neu1) in signalling during the immune response, phagocytosis and glucose uptake, as well as the role of neuraminidase 4 (Neu4) in brain development.

    Serine carboxypeptidases in regulation of vasoconstriction and elastogenesis

    Short vasoactive peptides are recognized as potent regulators of blood circulation. Through their interaction with different cell surface receptors, peptides can modulate blood pressure by diverse mechanisms such as contracting vascular smooth muscles, increasing or decreasing plasma volume, or inducing or suppressing vascular wall remodelling. Therefore, proteases involved in the catabolic proteolysis of circulating vasoactive peptides, which regulates their functional longevity and availability, play an important role in the regulation of vascular resistance. Using the knock-out mouse model we study the input of the major lysosomal serine carboxypeptidase A (cathepsin A) in post-translational processing of vasoactive peptides including angiotensin and endothelin.

    Functional proteomics and phosphoproteomics

    Phosphorylation is the most frequent and important post-translational modification of proteins. Despite intensive research dedicated to development of methods for the analysis of a phosphoproteome, identification of low-abundant cellular phosphoproteins still remains challenging, highlighting the need for novel techniques. Our team is involved in developing new technologies for the global analysis and quantitative analysis of a phosphoproteome based on affinity resins for isolation of phosphopeptides and phosphoproteins and isotopic peptide tags. This technology should allow comparison of phosphoproteomes tracing up- and down-regulation of the individual proteins in order to identify novel drug targets and pharmacologically relevant metabolic and signaling pathways.

    Awards and Distinctions

    • National Research Scholar, Fonds de la recherche en santé du Québec (FRSQ), April 2002.
    • Pediatric Excellence Award, Foundation of Stars, November 2001.
    • Senior Researcher Scholar, FRSQ, April 1999.
    • Junior 2 Research Scholar, FRSQ, June 1997.
About this page
Edited by Hoffmann Maude

Created on 9/18/2014
Alert or send a suggestion

Every dollar counts!

Thank you for your generosity.

It's people like you that allow us to accelerate research and heal more children better every year and, as such, offer among the best healthcare in the world.

It's also possible to give by mail or by calling toll-free

1-888-235-DONS (3667)

Contact Us

514 345-4931


© 2006-2014 CHU Sainte-Justine.
All rights reserved.
Terms of Use, Confidentiality, Security


Les informations contenues dans le site « CHU Sainte-Justine » ne doivent pas être utilisées comme un substitut aux conseils d’un médecin dûment qualifié et autorisé ou d’un autre professionnel de la santé. Les informations fournies ici le sont à des fins exclusivement éducatives et informatives.

Consultez votre médecin si vous croyez être malade ou composez le 911 pour toute urgence médicale.

CHU Sainte-Justine